Novel Psychoactive Substances

Classification, Pharmacology and Toxicology
Herausgeber: Dargan, Paul I; Wood, David M

• Gebundenes Buch

Produktbeschreibung

"Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, Second Edition provides readers with a comprehensive examination on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." The book covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance and a discussion of their associated acute and chronic harm and toxicity. This second edition addresses drugs new to the scene, with completely updated and revised chapters. Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals"--

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science
• 2nd edition
• Seitenzahl: 554
• Erscheinungstermin: 9. September 2021
• Englisch
• Abmessung: 239mm x 196mm x 32mm
• Gewicht: 1310g
• ISBN-13: 9780128187883
• ISBN-10: 0128187883
• Artikelnr.: 60182591

Inhaltsangabe

I. Background 1. Legal Classification and International Systems for
Monitoring Novel Psychoactive Substances 2. Availability and Supply of
Novel Psychoactive Substances 3. Prevalence of Use of Novel Psychoactive
Substances 4. Pharmacological Profiling of Novel Psychoactive Substances 5.
Novel methods of NPS detection and data triangulation 6. Social issues in
the use of novel psychoactive substances 7. General management of the
patient with Novel Psychoactive Substance Toxicity 8. Addiction and
treatment of Novel Psychoactive Substance dependence
II. Analytical Techniques 9. Analytical techniques for the detection of
novel psychoactive substances and their metabolites
III. Individual Novel Psychoactive Substances 10. Synthetic Amphetamines
including novel MDMA analogues 11. Pharmacology and Toxicology of
N-Benzyl-phenylethylamines (25X-NBOMe) Hallucinogens 12. 1-Benzylpiperazine
and other Piperazine-based stimulants 13. Cathinones 14. Arylcyclohexamines
15. Synthetic cannabinoids 16. Novel opioids 17. Novel benzodiazepines 18.
Tryptamines